Showing results (1841-1850 of 2,369) with videos related to
Sort By:
Pageof 237
European Urology|March 27, 2007
Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millenniumFelix K-H Chun, Alberto Briganti, Andrea Gallina, et al.European Urology Focus|October 21, 2023
Added Value of Prostate-specific Antigen Density in Selecting Prostate Biopsy Candidates Among Men with Elevated Prostate-specific Antigen and PI-RADS ≥3 Lesions on Multiparametric Magnetic Resonance Imaging of the Prostate: A Systematic Assessment by PI-RADS ScoreFrancesco Pellegrino, Armando Stabile, Gabriele Sorce, et al.Journal of Endourology|July 14, 2009
Thirty-day mortality after transurethral resection of the prostate in patients treated with androgen deprivation therapyHendrik Isbarn, Claudio Jeldres, Umberto Capitanio, et al.European Urology|August 21, 2020
Infertile Men Have Higher Prostate-specific Antigen Values than Fertile Individuals of Comparable AgeLuca Boeri, Paolo Capogrosso, Walter Cazzaniga, et al.British Journal of Cancer|October 3, 2013
Early expression of the fractalkine receptor CX3CR1 in pancreatic carcinogenesisG Celesti, G Di Caro, P Bianchi, et al.Clinical Genitourinary Cancer|March 10, 2019
Evaluation of Cause of Death After Radical Cystectomy for Patients With Bladder Cancer: The Impact of Age at the Time of SurgeryMarco Moschini, Alberto Martini, Stefania Zamboni, et al.European Urology Oncology|August 4, 2019
Consulting "Dr. Google" for Prostate Cancer Treatment Options: A Contemporary Worldwide Trend AnalysisGiovanni E Cacciamani, Silvia Bassi, Marco Sebben, et al.Annals of Surgery|October 26, 2012
Ultrasonic dissection versus conventional dissection techniques in pancreatic surgery: a randomized multicentre studyFaik G Uzunoglu, Anne Stehr, Judith A Fink, et al.The Prostate|July 2, 2026
Temporal Trends of Metastatic Prostate Cancer in the Prostate-Specific Membrane Antigen Positron Emission Tomography Era in the United StatesLeonardo Quarta, Maximilian Filzmayer, Michele Petix, et al.Urologic Oncology|August 5, 2026
Cancer-specific mortality in high-risk or very high-risk prostate cancer patients treated with focal therapy vs. radical prostatectomyLeonardo Quarta, Michele Petix, Maximilian Filzmayer, et al.Pageof 237